Part 7: Emerging Battlegrounds Cell and Gene Therapy, Trade Secret Thickets, and the Next Frontier Key Takeaways: Part 7 Cell and gene (C&G) therapies CAR-T, gene editing platforms, viral vector-based gene therapy, RNA therapies present a fundamentally different IP challenge than conventional pharmaceuticals
Estos parches estn siendo ofertados a travs de plataformas digitales, donde se les atribuyen propiedades para la reduccin de peso, sin contar con la autorizacin de la autoridad sanitaria, detall la entidad en un comunicado
36 Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, Wondisford FE, et al
Are the marketing claims proportional to the evidence
We often collaborate with primary care physicians, specialists, and therapists
In fact, following the period of supplementation, the activity of certain intrinsic antioxidant systems reached levels comparable to those observed in control subjects not exposed to the toxicants